In this study, targeting LINK‐A with the nucleic acid drug ASO could alleviate obesity and metabolic disorders in mice and further restore adipose tissue thermogenic capacity by remodeling the local microenvironment. Here, LINC01139 is linked to obesity due to melanocortin 4 receptor deficiency.